About EDAP TMS
EDAP TMS, the world leader in therapeutic ultrasound
Global leader in therapeutic ultrasound and present in the market for more than 35 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology using ultrasound technology. EDAP TMS is actively operating worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. By constantly investing in Research & Development, partnering with INSERM French public laboratory and internationally renowned medical research institutions, EDAP TMS has developed a strong valuable patent portfolio based on its innovative technologies.
HIFU (High Intensity Focused Ultrasound)
With its complete range of Robotic HIFU devices, Ablatherm® and Focal One®, EDAP TMS is the most innovative company in non-invasive treatment for Prostate Cancer. By combining the latest technologies in imaging and treatment modalities, EDAP TMS recently introduced the Focal One® device as the answer to current requirements for ideal focal therapy of prostate cancer and as a complement to the existing Ablatherm® HIFU.
ESWL (Extracorporeal ShockWave Lithotripsy)
As a pioneer and key player in the field of Extracorporeal ShockWave Lithotripsy, EDAP TMS introduced the first modular lithotripter. The latest generation of shockwave source (Electroconductive Technology) and stone localization (Visio-Track) are utilized exclusively by EDAP TMS in its Sonolith® range of ESWL systems (Sonolith® i-sys and Sonolith® i-move).
To offer a complete range of minimally invasive solutions covering the full scope of urinary tract stone indications, EDAP TMS has integrated in its portfolio an user-friendly 30W Holmium:YAG Surgical Laser the Laserlith® i-dust.
Laser i-dust® is not available for distribution in France, Morocco, Algeria and Tunisia as EDAP TMS is the exclusive distributor of Lumenis Holmium Lasers in these territories. For more information about Lumenis Holmium lasers, please visit the Lumenis websiteor contact us.